Unauthorized injectable peptide drugs recall in Canada: serious health risks
In plain language
This recall involves unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta. They are being recalled because they have not been assessed for safety, efficacy, or quality by Health Canada and may pose serious health risks. Consult a healthcare professional if you have used these products and follow the return/repair steps in the official notice.
What to do
- Consult a healthcare professional if you have been administered these drugs.
- Do not buy or use unauthorized drugs.
- Check product labels for an eight-digit DIN, NPN, or DIN-HM to confirm authorization.
- Report any health product-related side effects or complaints to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Serious health risks, including infection, allergic reactions, and interactions with other medications
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Serious health risks, including infection, allergic reactions, and interactions with other medications
What should consumers do?
Consult a healthcare professional if you have been administered these drugs. Do not buy or use unauthorized drugs. Check product labels for an eight-digit DIN, NPN, or DIN-HM to confirm authorization. Report any health product-related side effects or complaints to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Serious health risks, including infection, allergic reactions, and interactions with other medications
When was this product recalled?
This product was recalled on April 2, 2025.